Derek Thompson: So today you are the largest pharmaceutical company in the world, in significant part because of your GLP-1 drug
Veteran-owned and trusted by researchers (Trustpilot 4.8)
Puglisi S, Rossini A, Poli R et al (2021) Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system
Tambin se ha demostrado que los medicamentos reducen las complicaciones de la enfermedad renal, mejoran la salud del corazn y del hgado, tratan la apnea del sueo en adultos con sobrepeso, e incluso protegen el cerebro
The practical takeaway: Injection = high systemic distribution tendons, ligaments, muscle, joints, vascular tissue Oral = high local GI concentration intestinal lining, gastric mucosa, gut repair Nasal = intermediate systemic delivery potential neurological targeting, emerging evidence only Injectable BPC-157: Highest Bioavailability for Systemic and Musculoskeletal Goals Injectable BPC-157 is the best-studied delivery method for healing applications outside the gastrointestinal tract